$41.17
0.37% today
NYSE, Oct 15, 07:45 pm CET

CryoLife Stock price

$41.02
+1.26 3.17% 1M
+17.89 77.35% 6M
+12.43 43.48% YTD
+14.82 56.56% 1Y
+30.60 293.67% 3Y
+21.51 110.25% 5Y
+30.87 304.14% 10Y
+34.04 487.68% 20Y
NYSE, Closing price Tue, Oct 14 2025
+0.39 0.96%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$2.1b
Net debt
$165.9m
Cash
$53.5m
Shares outstanding
47.1m
Valuation (TTM | estimate)
P/E
negative | 360.0
P/S
4.8 | 4.3
EV/Sales
5.2 | 4.7
EV/FCF
274.3
P/B
4.6
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$405.0m | $446.8m
EBITDA
$36.3m | $89.7m
EBIT
$21.0m | $29.3m
Net Income
$-17.9m | $5.4m
Free Cash Flow
$7.7m
Growth (TTM | estimate)
Revenue
7.5% | 15.0%
EBITDA
-15.6% | 54.8%
EBIT
-23.0% | -29.5%
Net Income
-115.1% | 140.3%
Free Cash Flow
-16.7%
Margin (TTM | estimate)
Gross
64.0%
EBITDA
9.0% | 20.1%
EBIT
5.2%
Net
-4.4% | 1.2%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
35.0%
Return on Equity
-4.8%
ROCE
2.7%
ROIC
3.0%
Debt/Equity
0.5
More
EPS
$-0.4
FCF per Share
$0.2
Short interest
3.5%
Employees
2k
Rev per Employee
$240.0k
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

11x Buy
85%
2x Hold
15%

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

Buy
85%
Hold
15%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
405 405
7% 7%
100%
- Direct Costs 146 146
9% 9%
36%
259 259
6% 6%
64%
- Selling and Administrative Expenses 195 195
13% 13%
48%
- Research and Development Expense 28 28
2% 2%
7%
36 36
16% 16%
9%
- Depreciation and Amortization 15 15
3% 3%
4%
EBIT (Operating Income) EBIT 21 21
23% 23%
5%
Net Profit -18 -18
115% 115%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Neutral
PRNewsWire
2 days ago
30-day Data from the AMDS PERSEVERE Trial Demonstrates Visceral Malperfusion Resolution in 83%, and Renal Malperfusion Resolution in 74% of Affected Subjects Post-AMDS Implantation Real-World Data from the AMDS PROTECT Trial Validate Statistically Significant Positive Outcomes Demonstrated by the PERSEVERE and DARTS trials ATLANTA , Oct. 13, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a l...
Neutral
Seeking Alpha
about one month ago
Artivion, Inc. (NYSE:AORT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Company Participants James Mackin - Chairman, President & CEO Lance Berry - COO, CFO & Treasurer Presentation Unknown Analyst Perfect. Great. Thanks, everyone, for being with us.
Neutral
PRNewsWire
about one month ago
ATLANTA , Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel.
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today